Patent · US Active

Pharmaceutical package for ophthalmic formulations

US11654046B2 · kind B2 · utility

1Cited by

22References

32Claims

0Family size

Assignee

SIO2 MEDICAL PRODUCTS, LLC · US

Inventors

Christopher Weikart · Auburn, US
Murray Stephen Bennett · Bellingham, US
Jean-Pierre Giraud · Paris, FR

Key dates

Filing date	Nov 18, 2016
Grant date	May 23, 2023
Priority date	—
Expiry date	Feb 14, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A liquid formulation of an ophthalmic drug in a pharmaceutical package, for example a syringe, cartridge, or vial, made in part or in whole of a thermoplastic polymer, coated on the interior with a tie coating or layer, a barrier coating or layer, a pH protective coating or layer, and optionally a lubricity coating or layer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.